These following commitments outline our requirements for suppliers of poultry, eggs, pork, dairy and beef.
Scope
All supplier partners must comply with these standards when producing the following product groups for sale at Target.
Food
- Meat (beef, pork, lamb) and poultry (chicken, turkey).
- Eggs.
- Dairy products.
- Meat, poultry or dairy deli products.
Standards and commitments
We expect our vendor partners producing both owned brand and national brand food and beverage items to meet or exceed the following standards:
- Poultry: National Chicken Council (NCC) and National Turkey Federation (NTF) guidelines.
- Eggs: United Egg Producers (UEP) guidelines.
- Pork: Pork Quality Assurance+ (PQA+) and Transportation Quality Assurance+ (TQA+) and the Meat Institute slaughter guidelines.
- Dairy: Farmers Assuring Responsible Management (FARM) program.
- Beef: Meat Institute slaughter guidelines. Target supports its beef vendors transitioning to Dr. Temple Grandin’s Responsible Cattle Care Audit program.
Eggs
Target initially announced plans in 2016 to transition to a 100% cage-free egg supply chain by 2025, subject to available supply. Since that time, we have made meaningful progress while navigating significant industry volatility, including regulatory changes, supply constraints driven by avian influenza, and evolving consumer demand and pricing dynamics.
The egg industry has made meaningful progress recovering from the impacts of avian influenza, which significantly constrained supply and drove market volatility. As a result of this progress, and barring similar large-scale disruptions, Target is committed to providing our guests with an affordable and reliable 100% cage-free egg assortment by 2030. Target currently operates over 600 stores with a fully cage-free egg assortment, reflecting significant progress already underway across our footprint.
Target will advance a phased transition across at least 500 additional stores beginning in 2026 to inform a full chain approach to cage-free, while maintaining affordability and guest choice. As part of this phased approach, Target will:
- Reduce conventional private label SKUs and begin targeted assortment changes in selected stores. In October 2026 at least 200 of these initial 500 stores will convert to 100% cage-free eggs; at the remaining set of stores, one of Target’s two main non cage-free private label SKUs will fully transition to cage-free.
- Expand in-store and online communication starting in June to clearly identify cage-free options in our assortment—including in-aisle signage in all stores and online “badges” to guide guests to our cage-free options.
- By fall 2026, all private label cage-free egg cartons will be clearly identifiable to guests through a carton redesign that will make them significantly distinguishable from non cage-free options.
- Continue to review progress and refine implementation based on guest behavior, supply conditions, and affordability considerations.
Target currently sources over half of its eggs by unit volume from cage-free sources, ahead of many national grocery peers. We also continue to source 100% of liquid eggs from cage-free systems and expect to source 100% of National Brand eggs from cage-free sources by the end of 2026.
Target will pursue this transition through a phased approach, using the following annual ranges as milestones. We remain committed to reporting on progress annually. Our anticipated plans by year are as follows:
- End of 2026: 57–61% cage-free unit sales and 81% cage-free SKUs
- 2027: 62–70% cage-free unit sales and 87% cage-free SKUs
- 2028: 71–84% cage-free unit sales and 87% cage-free SKUs
- 2029: 85–90% cage-free unit sales and 94% cage-free SKUs
- 2030: 100% cage-free unit sales and 100% cage-free SKUs
These ranges reflect scenario-based projections and will be refined as we progress through implementation.
Progress against these benchmarks is subject to WIC compliance in certain states and potential industry disruptions (e.g., avian influenza). Target also remains committed to supporting legislation that expands WIC to allow for cage-free purchases. Notably, with Target’s support, Minnesota approved cage-free eggs as part of the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) in April 2025, expanding access for over 99,000 recipients. Target also supported a similar effort in New York, expanding access to cage-free eggs for over 450,000 WIC recipients as of April 2026.
Pork
Target established a goal in 2012 to eliminate gestation crates from our pork supply. In September 2022, we launched all Good & Gather fresh pork raised in an open pen gestation system, and we continue to maintain that standard.
Dairy
Target supports advances in dairy farming practices to include the use of genetic breeding programs to promote polled cattle (naturally hornless) to benefit the welfare of the cows and of the farmers who care for them by eliminating the need for dehorning.
Target supports the National Milk Producers Federation (NMPF) ban on tail docking.
Pain management
We ask all suppliers of meat, deli and dairy products to find and implement alternative solutions to painful procedures (for example, tail docking, de-horning and castration) where possible. We ask that pain management be used during the transition period of eliminating painful procedures.
Stunning requirements
Meat and poultry suppliers must ensure that animals are rendered unconscious and insensible to pain prior to slaughter, except where prohibited by religious constraint. Target supports the Orthodox Union ban on the shackling and hoist method for kosher slaughter and Dr. Temple Grandin’s Upright Restrain Box Method.
Antibiotics and antimicrobial3
We believe sick animals must be treated appropriately to end or reduce suffering. When antibiotics or antimicrobials are administered by a registered veterinarian, using them judiciously for therapeutic purposes, they play a critical role in the overall well-being of an animal.
However, we do not support the use of routine, non-therapeutic antimicrobials to promote growth or prevent disease. We expect our suppliers and the producers they work with to phase out these practices and only use antimicrobials when medically necessary.
There is greater risk to human health when antimicrobial-resistant bacteria develop due to overuse and misuse of certain medically-important antimicrobials. In response to this risk, we ask our suppliers to minimize and remove the use of those deemed critical for human health listed in the “2017 WHO guidelines on use of medically important antimicrobials in food-producing animals” and listed in FDA Guidance #152.